AIVITA Biomedical is a biotechnology company developing personalized vaccines that target multiple pathogens and tumor-initiating cells—the seed of all cancers—using our autologous personal immunotherapy platform.
Biotechnology company developing psychedelic entities for treating addiction.
Ceretype is developing neuroimaging systems to democratize discovery, development, and treatment with emerging therapeutic agents.
A life science company focused on mushroom derived medicines.
Diamond Therapeutics develops psilocybin based medicine while mitigating side-effects.
A digital media company covering psychedelics and all they intersect with, from healthcare disparities to the climate crisis.
Mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy, beginning with ketamine therapy.
Immersive virtual environments that improve the treatment of mental health.
Professional Education in Psychedelic-Assisted Psychotherapy and Integration.
Gwella's focus is on developing transformative consumer brands, products and technologies aimed at elevating people's health and wellbeing.
A clinical-stage neuroscience biotech transforming the treatment paradigm of psychiatric diseases.
GoodCap is developing effective mushroom-based treatments that open new pathways to a healthier future.
.png){kind=small}
